Medicamen Biotech Ltd Q3 FY2024-2025 Results: Summary
Revenue | ₹45.28Cr |
Net Profits | ₹3.47Cr |
Net Profit Margins | 7.66% |
Medicamen Biotech Ltd’s revenue fell -4.33% since last year same period to ₹45.28Cr in the Q3 2024-2025. On a quarterly growth basis, Medicamen Biotech Ltd has generated 0.56% jump in its revenue since last 3-months.
Medicamen Biotech Ltd’s net profit jumped 44.58% since last year same period to ₹3.47Cr in the Q3 2024-2025. On a quarterly growth basis, Medicamen Biotech Ltd has generated 137.67% jump in its net profits since last 3-months.
Medicamen Biotech Ltd’s net profit margin jumped 51.13% since last year same period to 7.66% in the Q3 2024-2025. On a quarterly growth basis, Medicamen Biotech Ltd has generated 136.36% jump in its net profit margins since last 3-months.
FAQs
What was the revenue for Medicamen Biotech Ltd in Q3 results 2024?
The revenue for Medicamen Biotech Ltd in the Q3 results 2024 was ₹45.28Cr.
What was the net profit for Medicamen Biotech Ltd in Q3 results 2024?
The net profit for Medicamen Biotech Ltd in the Q3 results 2024 was ₹3.47Cr.
What was the net profit margin for Medicamen Biotech Ltd in Q3 results 2024?
The net profit margin for Medicamen Biotech Ltd in the Q3 results 2024 was 7.66%.
What was the revenue for Medicamen Biotech Ltd in Q3 results 2023?
The revenue for Medicamen Biotech Ltd in the Q3 results 2023 was ₹47.33Cr.
What was the net profit for Medicamen Biotech Ltd in Q3 results 2023?
The net profit for Medicamen Biotech Ltd in the Q3 results 2023 was ₹2.40Cr.
What was the net profit margin for Medicamen Biotech Ltd in Q3 results 2023?
The net profit margin for Medicamen Biotech Ltd in the Q3 results 2023 was 5.07%.
